<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Wed, 13 May 2026 15:04:46 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/esketamine/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[FDA Approves Esketamine Nasal Spray For Hard-To-Treat Depression]]></title><description><![CDATA[Spravato, the brand name for esketamine, a newly approved option for treatment-resistant depression. Janssen Pharmaceutica The Food and Drug Administration approved the first drug that can relieve depression]]></description><link>http://direct.ecency.com/fda/@zubairarain/fda-approves-esketamine-nasal-spray-for-hard-to-treat-depression</link><guid isPermaLink="true">http://direct.ecency.com/fda/@zubairarain/fda-approves-esketamine-nasal-spray-for-hard-to-treat-depression</guid><category><![CDATA[fda]]></category><dc:creator><![CDATA[zubairarain]]></dc:creator><pubDate>Wed, 06 Mar 2019 06:38:57 GMT</pubDate><enclosure url="https://images.ecency.com/p/4BAcMbXZnLLKMhup8zh7w2pWg2mr8tygc18rdsnXvJ75GrbYusA1pVRMCxDDG1brFsei6rb3HQtz3ssgrSTi4gRRo3CrJFXdbnPB6pe87ccMAn6WpbFPWbB7LNpnSQYnmE7heizHC65LfQoyMC47rKJ8bRpCEP8VmtA5GbQDSfH3saDTdXXjG84CcjKGEAqrF8mKtGZHy13isK6vVVdK2P17Mjc?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>